Cardiovascular Risk of NSAIDS- Clinical implications Hina Zahid28 April 2021 11:39 AM ISTPain is a distressing feeling and is the commonest symptom in clinical practice. It affects the quality of life. Sleep can be disturbed. The...
Amlodipine and Atenolol - The two most time-tested anti-hypertensives of 21st century dr. Abhimanyu Uppal27 April 2021 12:42 PM ISTCardiovascular disease is the leading cause of death worldwide, and hypertension is a modifiable risk factor for cardiovascular disease. Risk...
The versatile drug Trimetazidine: Applications in angina and beyond Dr Tiny Nair26 April 2021 12:45 PM ISTTrimetazidine (TMZ), an anti-anginal agent with a unique pleiotropic profile of actions on the cardiac cells making it an effective anti-anginal...
Mavacamten in HOCM, is it good enough to replace older therapies? dr. Abhimanyu Uppal27 March 2021 11:15 AM ISTThe application of contemporary treatment strategies to hypertrophic cardiomyopathy (HCM) has transformed its prognosis from one of grim progression...
Propranolol and its current status in cardiovascular disorders dr. Abhimanyu Uppal25 March 2021 6:30 AM ISTPropranolol, initially introduced as an antianginal agent, has now established its benefits around a wide spectrum of medical disorders ranging from...
Cardiovascular benefits of ketone diet: just a gimmick or real science? dr. Abhimanyu Uppal16 March 2021 11:45 AM ISTMetabolic perturbations underlie a variety of cardiovascular disease states; yet, metabolic interventions to prevent or treat these disorders are...
Erectile Dysfunction: A precursor to cardiovascular disease? Raman Tanwar10 March 2021 11:00 AM ISTSince the first case of coronavirus, till today, if one thing we were able to internalise is, that a healthy body is a non-negotiable case in life....
Dissolving the dilemma: Management of Antithrombotic Therapy after Acute Coronary Syndromes dr. Abhimanyu Uppal24 Feb 2021 9:00 AM ISTThe management of antithrombotic agents for patients after an acute coronary syndrome is becoming increasingly complex. The data suggesting better...
Combination Therapy in Hypertension with Diabetes: Preferential Consideration for CCB and ARBs Dr. Pramila Kalra4 Jan 2021 12:45 PM ISTThe last edition of the International Diabetes Federation (IDF) Atlas offered projections that continue to put India at the second slot in the...
In a nutshell: The hottest developments in the field of cardiology in 2020. Section 5. Coronary artery disease dr. Abhimanyu Uppal31 Dec 2020 11:00 AM ISTCoronary artery disease (CAD) management id undoubtedly the most impactful arena of interventional cardiology. This year we witnessed several...
Hottest developments in field of cardiology in 2020 in nutshell. Section 4- Structural Heart disease dr. Abhimanyu Uppal29 Dec 2020 7:52 AM ISTThe year 2020 earmarked the expanding realm of transcatheter interventions to address aortic, tricuspid, and mitral valvular lesions and provide...
Avoiding Aldosterone Breakthrough in Hypertensive Diabetics: Role of Azelnidipine Prem Aggarwal28 Dec 2020 12:30 PM ISTAzelnidipine may contribute to avoid the "aldosterone breakthrough" by its suppressive effects on aldosterone synthesis and secretion
